Legal Opinion
Goodlin v. Medtronic, Inc.
Court of Appeals for the Eleventh Circuit
Decided February 18, 1999No. 97-5801PublishedCited by 59 opinions
1Opinion of the Court
KRAVITCH, Senior Circuit Judge:
This appeal requires us to determine the preemptive effect of the Medical Device Amendments (“MDA”), 21 U.S.C. § 360e et seq., to the Federal Food, Drug and Cosmetic Act (“FDCA”), 21 U.S.C. § 301 et seq. Lisa Goodlin brought suit against Medtronic, Inc. (“Medtronic”), alleging that her Med-tronic cardiac pacemaker lead was defective in a way that gave rise to two causes of action under Florida common law. Medtronic argues that because the United States Food and Drug Administration (the “FDA”) approved the device pursuant to the MDA’s premarket approval process,…
2Cases cited30 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- M'culloch v. State of MarylandSupreme Court of the United States · 1819
- Hines v. DavidowitzSupreme Court of the United States · 1941
- Rice v. Santa Fe Elevator Corp.Supreme Court of the United States · 1947
- Cipollone v. Liggett Group, Inc.Supreme Court of the United States · 1992
25 more not listed; retrieve them via the Exa API.
3Cited by59 opinions
- Shotz v. City of Plantation, FLCourt of Appeals for the Eleventh Circuit · 2003
- Amal Eghnayem v. Boston Scientific CorporationCourt of Appeals for the Eleventh Circuit · 2017
- Gomez v. St. Jude Medical Daig Division Inc.Court of Appeals for the Fifth Circuit · 2006
- Riegel v. Medtronic, Inc.Court of Appeals for the Second Circuit · 2006
- Elizabeth and Clifford Kemp v. Medtronic, Inc.Court of Appeals for the Sixth Circuit · 2000
54 more not listed; retrieve them via the Exa API.